This site is intended
for US residents 18 years of age or older.

This site is intended for US
residents 18 years of age or older.

For Healthcare Professionals

TERMS OF USE

Acceptance of Agreement. Your access to and use of the Bristol-Myers Squibb & Gilead Sciences, LLC Web site ("Site") is subject to the following terms and conditions and all applicable laws. By accessing and browsing the Site, you accept and agree to, without limitation or qualification, the terms and conditions and acknowledge that any other agreements between you and Bristol-Myers Squibb & Gilead Sciences, LLC are superseded and of no force or effect with respect to your access and use of this Site.

Scope of Use. Bristol-Myers Squibb & Gilead Sciences, LLC maintains this Site for your personal information, education and communication. Please feel free to browse the Site. You may download material displayed on the Site for non-commercial, personal use only, provided you maintain all copyright and other proprietary notices contained on the materials. You may not, however, distribute, modify, transmit, reuse, repost or use the content of the Site for public or commercial purposes, including the text and images, without written permission from Bristol-Myers Squibb & Gilead Sciences, LLC. You understand that Bristol-Myers Squibb & Gilead Sciences, LLC makes no representation that the information in the Site is appropriate or available for use in locations outside of the United States, and access to the Bristol-Myers Squibb & Gilead Sciences, LLC Site from territories where the content of the Site may be illegal or inappropriate is prohibited. Those who choose to access the Site from other locations do so of their own initiative and are responsible for compliance with applicable local laws.

No Medical Advice. The Site does not provide medical advice. With limited exception, the products of Bristol-Myers Squibb & Gilead Sciences, LLC are available only by prescription from a licensed healthcare professional. Bristol-Myers Squibb & Gilead Sciences, LLC are not engaged in rendering medical or similar professional services or advice, and the information provided on the Site is not intended to replace medical advice offered by a healthcare provider. If you desire or need such services or advice, you should promptly consult a physician or professional healthcare provider. Bristol-Myers Squibb & Gilead Sciences, LLC encourage patients to report any unwanted effects experienced following the use of their medicines. If you have any such reports or comments to make, do not make them via this site. Instead, such reports may be considered most effectively if you send them to the designated e-mail address for Bristol-Myers Squibb & Gilead Sciences, LLC: drugreaction@gilead.com.

Product Information. The product information provided on the Site is intended only for residents in the United States. The Site and its links may, however, contain information about products that may or may not be available in any particular country, territory or region of the world (including the United States), may be available under different trademarks in different countries and, where applicable, may be approved or cleared by a government regulatory body for sale or use with different indications and restrictions in different countries. You should not construe anything on the Site as a promotion or solicitation for any product or service or for the use of any product or service that is not authorized by the laws and regulations of the country where you are located, including the United States. For specific information about particular products, you should refer to the Full Prescribing Information as approved by the relevant governmental authority of the country where you are located. The prescribing information provided here is based on United States labeling and may not be appropriate outside of the United States.

Copyright Protection. You should assume that everything you see or read on the Site is copyrighted, unless otherwise noted, and may not be used except as provided in these terms and conditions or in the text on the Site without the written permission of Bristol-Myers Squibb & Gilead Sciences, LLC. Bristol-Myers Squibb & Gilead Sciences, LLC neither warrants nor represents that your use of materials displayed on the Site will not infringe rights of third parties not owned by or affiliated with Bristol-Myers Squibb & Gilead Sciences, LLC.

Trademarks. The trademarks, trade names, logos and service marks (collectively the "Trademarks") displayed on the Site are registered and unregistered Trademarks of Bristol-Myers Squibb & Gilead Sciences, LLC and others. Nothing contained on the Site should be construed as granting, by implication, estoppel or otherwise, any license or right to use any Trademark displayed on the Site without the written permission of Bristol-Myers Squibb & Gilead Sciences, LLC or such third party that may own the Trademark displayed on the Site. Your use of the Trademarks displayed on the Site, or any other content on the Site, except as provided in these terms and conditions, is strictly prohibited. You are also advised that Bristol-Myers Squibb & Gilead Sciences, LLC will aggressively enforce its intellectual property rights to the fullest extent of the law, including the seeking of criminal prosecution.

Exclusion of Warranty. While Bristol-Myers Squibb & Gilead Sciences, LLC uses reasonable efforts to include accurate and up-to-date information in the Site, Bristol-Myers Squibb & Gilead Sciences, LLC makes no warranties or representations as to its accuracy. Bristol-Myers Squibb & Gilead Sciences, LLC assumes no liability or responsibility for any errors or omissions in the content of the Site. Without limiting the foregoing, everything on the Site is provided to you "AS IS" WITHOUT WARRANTY OF ANY KIND, EITHER EXPRESSED OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE OR NON-INFRINGEMENT. Please note that some jurisdictions may not allow the exclusion of implied warranties, so some of the above exclusions may not apply to you. Check your local laws for any restrictions or limitations regarding the exclusion of implied warranties.

Limitation of Liability. Your use of and browsing in the Site are at your risk. Neither Bristol-Myers Squibb & Gilead Sciences, LLC, nor any other party involved in creating, producing or delivering the Site is liable for any direct, incidental, consequential, indirect or punitive damages arising out of your access to, or use of, the Site. Bristol-Myers Squibb & Gilead Sciences, LLC assumes no responsibility, and shall not be liable for any damages to, or viruses that may infect, your computer equipment or other property on account of your access to, use of, or browsing in the Site or your downloading of any materials, data, text or images from the Site.

User Submissions. Any "personally identifiable information" submitted to the Site during the registration process is governed by the Site's Privacy Policy. This Site allows you to receive additional information as it becomes available.

Links to Other Sites. Bristol-Myers Squibb & Gilead Sciences, LLC have not reviewed all of the sites linked to the Site and are not responsible for the content of any off-site pages or any other sites linked to the Site. Your linking to any other off-site pages or other sites is at your own risk. Once you link to another site, please be sure to review the legal notice and privacy policy of the new site. It may be different from those governing the Site.

Governing Law. This agreement and its performance shall be governed by the laws of the state of New Jersey, United States of America, without regard to its conflict of laws provisions. You consent and submit to the exclusive jurisdiction of the state and federal courts located in the state of New Jersey, United States of America, in all questions and controversies arising out of your use of the Site and this Agreement. To the extent allowed by applicable law, any claim or cause of action arising from or relating to your access or use of the Site must be brought within two (2) years from the date on which such claim or action arose or accrued.

Modification of Agreement. Bristol-Myers Squibb & Gilead Sciences, LLC may, at any time, revise the terms and conditions of this agreement governing use of the Site. If any terms and conditions contained in this Legal Notice are changed, the amended notice will be posted on the Site. You are bound by any such revisions and should, therefore, periodically review these terms and conditions.

More Important Safety Information 

IMPORTANT SAFETY INFORMATION

What is the most important information I should know about ATRIPLA?

ATRIPLA can cause serious side effects:

  • Some people who have taken medicines like ATRIPLA (which contains nucleoside analogs) have developed lactic acidosis (build up of an acid in the blood). Lactic acidosis can be a serious medical emergency that can lead to death.

    Call your healthcare provider right away if you get the following signs or symptoms of lactic acidosis:

    • feel very weak or tired
    • have unusual (not normal) muscle pain
    • have trouble breathing
    • have stomach pain with nausea and vomiting
    • feel cold, especially in your arms and legs
    • feel dizzy or lightheaded
    • have a fast or irregular heartbeat
  • Some people who have taken medicines like ATRIPLA have developed serious liver problems (hepatotoxicity), with liver enlargement (hepatomegaly) and fat in the liver (steatosis). In some cases, these liver problems can lead to death.

    Call your healthcare provider right away if you get the following signs or symptoms of liver problems:

    • skin or the white part of your eyes turns yellow (jaundice)
    • urine turns dark
    • bowel movements (stools) turn light in color
    • don’t feel like eating food for several days or longer
    • feel sick to your stomach (nausea)
    • have lower stomach area (abdominal) pain
  • You may be more likely to get lactic acidosis or liver problems if you are female, very overweight (obese), or have been taking nucleoside analog-containing medicines, like ATRIPLA (efavirenz/emtricitabine/tenofovir disoproxil fumarate), for a long time.
  • If you also have hepatitis B virus (HBV) infection and you stop taking ATRIPLA, you may get a “flare-up” of your hepatitis. A “flare-up” is when the disease suddenly returns in a worse way than before. Patients with HBV who stop taking ATRIPLA need close medical follow-up for several months to check for hepatitis that could be getting worse. ATRIPLA is not approved for the treatment of HBV, so you need to discuss your HBV therapy with your healthcare provider.

Who should not take ATRIPLA?

You and your healthcare provider should decide if ATRIPLA is right for you. Do not take ATRIPLA if you are allergic to ATRIPLA or any of its ingredients.

What should I tell my healthcare provider before taking ATRIPLA?

Tell your healthcare provider if you:

  • Are pregnant or planning to become pregnant: Women should not become pregnant while taking ATRIPLA and for 12 weeks after stopping ATRIPLA. Serious birth defects have been seen in children of women treated during pregnancy with efavirenz, one of the medicines in ATRIPLA. Women must use a reliable form of barrier contraception, such as a condom or diaphragm, even if they also use other methods of birth control, while on ATRIPLA and for 12 weeks after stopping ATRIPLA. Women should not rely only on hormone-based birth control, such as pills, injections, or implants, because ATRIPLA may make these contraceptives ineffective.
  • Are breastfeeding: Women with HIV should not breastfeed because they can pass HIV and some of the medicines in ATRIPLA through their milk to the baby. It is not known if ATRIPLA could harm your baby.
  • Have kidney problems or are undergoing kidney dialysis treatment.
  • Have bone problems.
  • Have liver problems, including hepatitis B or C virus infection. Your healthcare provider may want to do tests to check your liver while you take ATRIPLA or may switch you to another medicine.
  • Have ever had mental illness or are using drugs or alcohol.
  • Have ever had seizures or are taking medicine for seizures. Seizures have occurred in patients taking efavirenz, a component of ATRIPLA, generally in those with a history of seizures. If you have ever had seizures, or take medicine for seizures, your healthcare provider may want to switch you to another medicine or monitor you.

What important information should I know about taking other medicines with ATRIPLA?

ATRIPLA may change the effect of other medicines, including the ones for HIV-1, and may cause serious side effects. Your healthcare provider may change your other medicines or change their doses.

MEDICINES YOU SHOULD NOT TAKE WITH ATRIPLA

  • ATRIPLA should not be taken with: Combivir® (lamivudine/zidovudine), COMPLERA® (emtricitabine/rilpivirine/tenofovir disoproxil fumarate), EMTRIVA® (emtricitabine), Epivir® or Epivir-HBV® (lamivudine), Epzicom® (abacavir sulfate/lamivudine), STRIBILD® (elvitegravir/cobicistat/emtricitabine/tenofovir DF), Trizivir® (abacavir sulfate/lamivudine/zidovudine), TRUVADA® (emtricitabine/tenofovir DF), or VIREAD® (tenofovir DF), because they contain the same or similar active ingredients as ATRIPLA. ATRIPLA should not be used with SUSTIVA® (efavirenz) unless recommended by your healthcare provider.
  • Vfend® (voriconazole) should not be taken with ATRIPLA since it may lose its effect or may increase the chance of having side effects from ATRIPLA.
  • ATRIPLA should not be used with HEPSERA® (adefovir dipivoxil).

These are not all the medicines that may cause problems if you take ATRIPLA. Tell your healthcare provider about all prescription and nonprescription medicines, vitamins, or herbal supplements you are taking or plan to take.

What are the possible side effects of ATRIPLA?

ATRIPLA may cause the following additional serious side effects:

  • Serious psychiatric problems. Severe depression, strange thoughts, or angry behavior have been reported by a small number of patients. Some patients have had thoughts of suicide, and a few have actually committed suicide. These problems may occur more often in patients who have had mental illness.
  • Kidney problems (including decline or failure of kidney function). If you have had kidney problems, or take other medicines that may cause kidney problems, your healthcare provider should do regular blood tests. Symptoms that may be related to kidney problems include a high volume of urine, thirst, muscle pain, and muscle weakness.
  • Other serious liver problems. Some patients have experienced serious liver problems, including liver failure resulting in transplantation or death. Most of these serious side effects occurred in patients with a chronic liver disease such as hepatitis infection, but there have also been a few reports in patients without any existing liver disease.
  • Changes in bone mineral density (thinning bones). Lab tests show changes in the bones of patients treated with tenofovir DF, a component of ATRIPLA. Some HIV patients treated with tenofovir DF developed thinning of the bones (osteopenia), which could lead to fractures. Also, bone pain and softening of the bone (which may lead to fractures) may occur as a consequence of kidney problems. If you have had bone problems in the past, your healthcare provider may want to do tests to check your bones or may prescribe medicines to help your bones.

Common side effects:

  • Patients may have dizziness, headache, trouble sleeping, drowsiness, trouble concentrating, and/or unusual dreams during treatment with ATRIPLA (efavirenz/emtricitabine/tenofovir disoproxil fumarate). These side effects may be reduced if you take ATRIPLA at bedtime on an empty stomach; they tend to go away after taking ATRIPLA for a few weeks. Tell your healthcare provider right away if any of these side effects continue or if they bother you. These symptoms may be more severe if ATRIPLA is used with alcohol and/or mood-altering (street) drugs.
  • If you are dizzy, have trouble concentrating, and/or are drowsy, avoid activities that may be dangerous, such as driving or operating machinery.
  • Rash is a common side effect with ATRIPLA that usually goes away without any change in treatment. Rash may be serious in a small number of patients. Rash occurs more commonly in children and may be a serious problem. If a rash develops, call your healthcare provider right away.
  • Other common side effects include: tiredness, upset stomach, vomiting, gas, and diarrhea.

Other possible side effects:

  • Changes in body fat have been seen in some people taking anti-HIV-1 medicines. Increase of fat in the upper back and neck, breasts, and around the trunk may happen. Loss of fat from the legs, arms, and face may also happen. The cause and long-term health effects of these changes in body fat are not known.
  • Skin discoloration (small spots or freckles) may also happen.
  • In some patients with advanced HIV infection (AIDS), signs and symptoms of inflammation from previous infections may occur soon after anti-HIV treatment is started. If you notice any symptoms of infection, contact your healthcare provider right away.
  • Additional side effects are inflammation of the pancreas, allergic reaction (including swelling of the face, lips, tongue, or throat), shortness of breath, pain, stomach pain, weakness, and indigestion.

This is not a complete list of side effects. Tell your healthcare provider or pharmacist if you notice any side effects while taking ATRIPLA.

You should take ATRIPLA once daily on an empty stomach. Taking ATRIPLA at bedtime may make some side effects less bothersome.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Please see Full Prescribing Information, including “What is the most important information I should know about ATRIPLA” in the Patient Information section.

More Important Safety Information  

SELECTED IMPORTANT SAFETY INFORMATION

What is the most important information I should know about ATRIPLA?

ATRIPLA can cause serious side effects:

  • Some people who have taken medicines like ATRIPLA (which contains nucleoside analogs) have developed lactic acidosis (build up of an acid in the blood). Lactic acidosis can be a serious medical emergency that can lead to death.

    Call your healthcare provider right away if you get the following signs or symptoms of lactic acidosis:

    • feel very weak or tired
    • have unusual (not normal) muscle pain
    • have trouble breathing
    • have stomach pain with nausea and vomiting
    • feel cold, especially in your arms and legs
    • feel dizzy or lightheaded
    • have a fast or irregular heartbeat
  • Some people who have taken medicines like ATRIPLA have developed serious liver problems (hepatotoxicity), with liver enlargement (hepatomegaly) and fat in the liver (steatosis). In some cases, these liver problems can lead to death.

    Call your healthcare provider right away if you get the following signs or symptoms of liver problems:

    • skin or the white part of your eyes turns yellow (jaundice)
    • urine turns dark
    • bowel movements (stools) turn light in color
    • don’t feel like eating food for several days or longer
    • feel sick to your stomach (nausea)
    • have lower stomach area (abdominal) pain
  • You may be more likely to get lactic acidosis or liver problems if you are female, very overweight (obese), or have been taking nucleoside analog-containing medicines, like ATRIPLA (efavirenz/emtricitabine/tenofovir disoproxil fumarate), for a long time.
  • If you also have hepatitis B virus (HBV) infection and you stop taking ATRIPLA, you may get a “flare-up” of your hepatitis. A “flare-up” is when the disease suddenly returns in a worse way than before. Patients with HBV who stop taking ATRIPLA need close medical follow-up for several months to check for hepatitis that could be getting worse. ATRIPLA is not approved for the treatment of HBV, so you need to discuss your HBV therapy with your healthcare provider.